Glyxambi 25 mg/1

Glyxambi 25 mg/1 is a combination medication containing empagliflozin and linagliptin, used to manage type 2 diabetes. This oral tablet helps control blood sugar levels and is available in a 90-tablet bottle.

Glyxambi 25 mg/1 is primarily used to manage type 2 diabetes by improving blood sugar control. Empagliflozin works by helping the kidneys remove excess glucose from the body, while linagliptin helps the pancreas produce more insulin. This combination can be part of a broader diabetes management plan, including diet and exercise.

Common effects of Glyxambi 25 mg/1 may include urinary tract infections, genital fungal infections, and low blood sugar when combined with other diabetes medications. Some users may also experience headaches, dizziness, or gastrointestinal discomfort. Always consult a healthcare provider for personalized advice.

Glyxambi 25 mg/1 should be handled with care, especially for those with kidney issues or a history of pancreatitis. It is important to stay hydrated and monitor blood sugar levels regularly. Always follow the guidance of a healthcare professional when starting or adjusting any medication.

Glyxambi 25 mg/1 may interact with other medications, including insulin, other diabetes drugs, and certain antibiotics. Alcohol and some over-the-counter medications can also affect its efficacy. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.